Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations
2nd February 2022 Uncategorised 0 Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations
kdunleavy
Wed, 02/02/2022 – 11:52
More: Humira rings up .7B in 2021, but AbbVie still mum on post-biosimilar expectations
Source: fierce